Sarepta Therapeutics | ADÓSSÁG

Debt változás Dátum
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.14M 84K 2022-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amgen USD 64.61B 4.15B 2023-12
BioCryst Pharmaceuticals USD 833.18M 13.88M 2023-09
Biogen USD 6.94B 348.2M 2023-12
BioMarin Pharmaceutical USD 1.09B 988K 2023-12
Bluebird Bio USD 0 0 2022-06
Capricor Therapeutics USD 3.38M 0 2023-09
Daiichi Sankyo JPY 101.9B 41.09B 2023-09
Eli Lilly USD 20.17B 1.35B 2023-09
Esperion Therapeutics USD 261.16M 427K 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
Incyte USD 32.6M 678K 2023-12
Insmed USD 1.18B 7.19M 2023-12
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Moderna USD 575M 150M 2023-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 169.9M 200K 2023-09
Novavax USD 222.11M 23.17M 2023-09
Pfizer USD 63.6B 1.74B 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Roche Holding CHF 25.39B 35M 2023-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Sarepta Therapeutics ADÓSSÁG - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Apr 2024.